{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "interpro:IPR002908",
      "entity_text" : "frataxin",
      "entity_type" : "family"
    },
    "hypothesis_information" : false,
    "context" : {
      "Cellular_component" : [ "go:GO:0005739" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "FRDA patients live with a reduced and insufficient amount of frataxin protein; thus, the main goal of a specific therapy for Friedreich ataxia would be to restore physiological frataxin levels.",
  "reading_complete" : "2020-08-08T16:20:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T16:16:04Z",
  "trigger" : "levels",
  "evidence" : [ "frataxin levels" ],
  "pmc_id" : "5329121",
  "score" : 0
}